Literature DB >> 20712408

Mitochondrial liaisons of p53.

Lorenzo Galluzzi1, Eugenia Morselli, Oliver Kepp, Ilio Vitale, Marcello Pinti, Guido Kroemer.   

Abstract

Mitochondria play a central role in cell survival and cell death. While producing the bulk of intracellular ATP, mitochondrial respiration represents the most prominent source of harmful reactive oxygen species. Mitochondria participate in many anabolic pathways, including cholesterol and nucleotide biosynthesis, yet also control multiple biochemical cascades that contribute to the programmed demise of cells. The tumor suppressor protein p53 is best known for its ability to orchestrate a transcriptional response to stress that can have multiple outcomes, including cell cycle arrest and cell death. p53-mediated tumor suppression, however, also involves transcription-independent mechanisms. Cytoplasmic p53 can physically interact with members of the BCL-2 protein family, thereby promoting mitochondrial membrane permeabilization. Moreover, extranuclear p53 can suppress autophagy, a major prosurvival mechanism that is activated in response to multiple stress conditions. Thirty years have passed since its discovery, and p53 has been ascribed with an ever-increasing number of functions. For instance, p53 has turned out to influence the cell's redox status, by transactivating either anti- or pro-oxidant factors, and to regulate the metabolic switch between glycolysis and aerobic respiration. In this review, we will analyze the mechanisms by which p53 affects the balance between the vital and lethal functions of mitochondria.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20712408     DOI: 10.1089/ars.2010.3504

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  32 in total

1.  Phospho-ΔNp63α/miR-885-3p axis in tumor cell life and cell death upon cisplatin exposure.

Authors:  Yiping Huang; Alice Y Chuang; Edward A Ratovitski
Journal:  Cell Cycle       Date:  2011-11-15       Impact factor: 4.534

Review 2.  Driving apoptosis-relevant proteins toward neural differentiation.

Authors:  Susana Solá; Márcia M Aranha; Cecília M P Rodrigues
Journal:  Mol Neurobiol       Date:  2012-07-01       Impact factor: 5.590

3.  Inhibiting eukaryotic transcription: Which compound to choose? How to evaluate its activity?

Authors:  Olivier Bensaude
Journal:  Transcription       Date:  2011-05

4.  Drp1 stabilizes p53 on the mitochondria to trigger necrosis under oxidative stress conditions in vitro and in vivo.

Authors:  Xing Guo; Hiromi Sesaki; Xin Qi
Journal:  Biochem J       Date:  2014-07-01       Impact factor: 3.857

Review 5.  Genome Stability Requires p53.

Authors:  Christine M Eischen
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

6.  Mitochondrial translocation of p53 modulates neuronal fate by preventing differentiation-induced mitochondrial stress.

Authors:  Joana M Xavier; Ana L Morgado; Susana Solá; Cecília M P Rodrigues
Journal:  Antioxid Redox Signal       Date:  2014-03-12       Impact factor: 8.401

Review 7.  Metabolic regulation of oxygen and redox homeostasis by p53: lessons from evolutionary biology?

Authors:  Jie Zhuang; Wenzhe Ma; Cory U Lago; Paul M Hwang
Journal:  Free Radic Biol Med       Date:  2012-07-25       Impact factor: 7.376

8.  Cyclophilin D counteracts P53-mediated growth arrest and promotes Ras tumorigenesis.

Authors:  A Bigi; E Beltrami; M Trinei; M Stendardo; P G Pelicci; M Giorgio
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

9.  Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration.

Authors:  Xing Guo; Marie-Helene Disatnik; Marie Monbureau; Mehrdad Shamloo; Daria Mochly-Rosen; Xin Qi
Journal:  J Clin Invest       Date:  2013-11-15       Impact factor: 14.808

10.  Analysis of Proapoptotic Protein Trafficking to and from Mitochondria.

Authors:  Ignacio Vega-Naredo; Gabriela Oliveira; Teresa Cunha-Oliveira; Teresa Serafim; Vilma A Sardão; Paulo J Oliveira
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.